Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders

NCT02981173 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02981173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02981173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
December 5, 2016
Completion date
October 21, 2022
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cluster headache